Free Trial

ViewRay (VRAYQ) Competitors

VRAYQ vs. AFIB, BRSH, SDCCQ, GMVDF, NMRD, UTRS, MOTS, VIVE, DRTSW, and ANZUW

Should you be buying ViewRay stock or one of its competitors? The main competitors of ViewRay include Acutus Medical (AFIB), Bruush Oral Care (BRSH), SmileDirectClub (SDCCQ), G Medical Innovations (GMVDF), Nemaura Medical (NMRD), Minerva Surgical (UTRS), Motus GI (MOTS), Viveve Medical (VIVE), Alpha Tau Medical (DRTSW), and Anzu Special Acquisition Corp I (ANZUW). These companies are all part of the "medical equipment" industry.

ViewRay vs. Its Competitors

Acutus Medical (NASDAQ:AFIB) and ViewRay (NASDAQ:VRAYQ) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, media sentiment, dividends, institutional ownership, analyst recommendations, valuation, earnings and risk.

56.9% of Acutus Medical shares are owned by institutional investors. Comparatively, 15.5% of ViewRay shares are owned by institutional investors. 5.2% of Acutus Medical shares are owned by company insiders. Comparatively, 2.5% of ViewRay shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Acutus Medical's average media sentiment score of 0.00 equaled ViewRay'saverage media sentiment score.

Company Overall Sentiment
Acutus Medical Neutral
ViewRay Neutral

Acutus Medical has higher earnings, but lower revenue than ViewRay.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acutus Medical$7.16M0.00-$81.66MN/AN/A
ViewRay$102.21M0.00-$107.33MN/AN/A

Acutus Medical has a beta of -0.57, indicating that its stock price is 157% less volatile than the S&P 500. Comparatively, ViewRay has a beta of 1.05, indicating that its stock price is 5% more volatile than the S&P 500.

ViewRay has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. ViewRay's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Acutus Medical-272.74% -311.64% -11.57%
ViewRay N/A N/A N/A

Summary

ViewRay beats Acutus Medical on 5 of the 8 factors compared between the two stocks.

Get ViewRay News Delivered to You Automatically

Sign up to receive the latest news and ratings for VRAYQ and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VRAYQ vs. The Competition

MetricViewRayElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$18K$32.53M$5.70B$9.51B
Dividend YieldN/AN/A4.69%4.01%
P/E RatioN/A2.8728.0720.05
Price / SalesN/A195.12448.5799.42
Price / CashN/A41.3636.2258.56
Price / BookN/A2.038.665.87
Net Income-$107.33M-$2.66M$3.25B$258.55M

ViewRay Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VRAYQ
ViewRay
N/AN/AN/AN/A$18K$102.21M0.00300
AFIB
Acutus Medical
N/A$0.01
+150.0%
N/A-99.5%$66K$7.16M0.00340Gap Up
BRSH
Bruush Oral Care
N/AN/AN/AN/A$44K$2.92M0.0011Gap Down
SDCCQ
SmileDirectClub
N/A$0.00
flat
N/AN/A$40K$470.74M0.002,700
GMVDF
G Medical Innovations
N/A$0.00
flat
N/AN/A$26K$4.42M0.0072
NMRD
Nemaura Medical
1.1529 of 5 stars
N/AN/A-99.4%$4K$3.02K0.0040
UTRS
Minerva Surgical
N/AN/AN/AN/A$1K$51.69M0.00160
MOTS
Motus GI
N/A$0.00
-66.7%
N/A-99.8%$1K$319K0.0030Gap Down
High Trading Volume
VIVE
Viveve Medical
N/AN/AN/A-66.7%$1K$6.83M0.0070
DRTSW
Alpha Tau Medical
N/A$0.27
-2.1%
N/A+6.4%$0.00N/A0.0080Positive News
ANZUW
Anzu Special Acquisition Corp I
N/A$0.06
flat
N/AN/A$0.00N/A0.002

Related Companies and Tools


This page (NASDAQ:VRAYQ) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners